News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN) Spinoff Atara Biotherapeutics Hikes IPO Target From $50 Million To $92 Million


7/11/2014 8:16:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Atara Biotherapeutics Inc. supersized its planned IPO to up to $92 million, offering 5.75 million shares at a range of $14 to $16 each.

The Brisbane spinout of Amgen Inc., which counts among its investors legendary Mexican billionaire Carlos Slim, last month eyed a $50 million initial public offering. Now it is the second Bay Area life sciences company this week to raise its IPO target.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES